NCT00003816 arm group baa2670dbc2b9a685f6c6247d9dd78c0 [clinicaltrials_resource:NCT00003816/arm-group/baa2670dbc2b9a685f6c6247d9dd78c0]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00003816 arm group baa2670dbc2b9a685f6c6247d9dd78c0 [clinicaltrials_resource:NCT00003816/arm-group/baa2670dbc2b9a685f6c6247d9dd78c0]
Bio2RDF identifier
NCT00003816/arm-group/baa2670dbc2b9a685f6c6247d9dd78c0
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... a2670dbc2b9a685f6c6247d9dd78c0
description [clinicaltrials_vocabulary:description]
Patients receive fludarabine I ...... er 4-8 hours on days -5 to -2.
identifier
clinicaltrials_resource:NCT00003816/arm-group/baa2670dbc2b9a685f6c6247d9dd78c0
title
NCT00003816 arm group baa2670dbc2b9a685f6c6247d9dd78c0
@en
type
label
NCT00003816 arm group baa2670d ...... 2670dbc2b9a685f6c6247d9dd78c0]
@en